These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6878262)

  • 21. [Changes in the filtration function of the kidneys during the treatment of chronic glomerulonephritis].
    Riabov SI; Stavskaia VV; Kozlov VV; Kucher AG
    Ter Arkh; 1994; 66(8):52-7. PubMed ID: 7985156
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Standard of prognostic judgments of chronic glomerulonephritis--kidney function].
    Abe H; Furukawa T
    Nihon Rinsho; 1966 Apr; 24(4):691-8. PubMed ID: 6007500
    [No Abstract]   [Full Text] [Related]  

  • 23. [Fenofibrate increases blood creatinine, but does not change the glomerular filtration rate in patients with mild renal insufficiency].
    Hottelart C; el Esper N; Achard JM; Pruna A; Fournier A
    Nephrologie; 1999; 20(1):41-4. PubMed ID: 10081035
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nephrotoxicity and acute renal failure associated with cephalothin and cephaloridine.
    Simpson IJ
    N Z Med J; 1971 Nov; 74(474):312-5. PubMed ID: 5289757
    [No Abstract]   [Full Text] [Related]  

  • 25. [Clinical effect of treatment with lipo-prostaglandin E1 on the patients with chronic glomerulonephritis].
    Zhong WQ; Liu GX; Yang YM; Cai X; Huang ZL
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2004 May; 16(5):292-4. PubMed ID: 15132795
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Azotaemia aggravated by oxytetracycline.
    Mehrotra TN; Gupta AK
    J Indian Med Assoc; 1971 Nov; 57(10):383-4. PubMed ID: 5140825
    [No Abstract]   [Full Text] [Related]  

  • 27. Comparison of glomerular filtration rate, blood urea nitrogen and serum creatinine in patients with chronic urinary tract disease.
    Price M; Kottke FJ
    Minn Med; 1980 Nov; 63(11):781-2. PubMed ID: 7453696
    [No Abstract]   [Full Text] [Related]  

  • 28. Tetracycline and blood urea.
    Br Med J; 1972 Aug; 3(5823):370. PubMed ID: 5070158
    [No Abstract]   [Full Text] [Related]  

  • 29. [Effect of protein load on kidney functions in patients with chronic glomerulonephritis].
    Esaian AM; Kucher AG; Kaiukov IG; Ermakov IuA; Nikogosian IuA; Riabov SI
    Ter Arkh; 2002; 74(6):19-24. PubMed ID: 12136476
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Analysis of causes of decreased reactivity of the kidney to furosemide in newborn infants and children with chronic glomerulonephritis].
    Natochin IuV; Govyrin VA; Papaian AV; Zhukovskaia EA; Lavrova EA
    Pediatriia; 1983 Jul; (7):24-6. PubMed ID: 6356015
    [No Abstract]   [Full Text] [Related]  

  • 31. [Tubular reabsorption of urea during diuretic therapy].
    Conte G; Dal Canton A; Fuiano G; Sabbatini M; Terribile M; Andreucci VE
    Minerva Nefrol; 1982; 29(2):89-92. PubMed ID: 7133544
    [No Abstract]   [Full Text] [Related]  

  • 32. [Management of drug therapy in presence of renal insufficiency].
    Fabre J
    Rev Med Suisse Romande; 1972 Dec; 92(12):983-94. PubMed ID: 4665194
    [No Abstract]   [Full Text] [Related]  

  • 33. [Variants in the transient deterioration of kidney function in chronic glomerulonephritis].
    Riabov SI; Stavskaia VV
    Ter Arkh; 1996; 68(11):62-7. PubMed ID: 9045385
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Vitamin K1 and C excretion by the kidneys in chronic kidney failure].
    Bakaev VV; Khomenko VF; Titiaev II
    Urol Nefrol (Mosk); 1993; (6):42-4. PubMed ID: 8160321
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of standard heart failure therapy and concomitant treatment with intravenous furosemide or inotropes (dobutamine, dopamine, and/or milrinone) on renal function and mortality in patients treated with nesiritide.
    Kurien S; Warfield KT; Wood CM; Miller WL
    Am J Cardiol; 2006 Dec; 98(12):1627-30. PubMed ID: 17145223
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PGl2 analogue mitigates the progression rate of renal dysfunction improving renal blood flow without glomerular hyperfiltration in patients with chronic renal insufficiency.
    Fujita T; Fuke Y; Satomura A; Hidaka M; Ohsawa I; Endo M; Komatsu K; Ohi H
    Prostaglandins Leukot Essent Fatty Acids; 2001 Oct; 65(4):223-7. PubMed ID: 11728176
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical aspects and therapy of chronic renal insufficiency].
    Albertazzi A; Spisni C; Cappelli P; Palmieri PF; Di Paolo B; Del Rosso G
    Minerva Med; 1982 Feb; 73(6):249-54. PubMed ID: 7036007
    [No Abstract]   [Full Text] [Related]  

  • 38. [Increase in glomerular filtration by phospholipids].
    Deibert K; Juchems R
    Munch Med Wochenschr; 1966 Dec; 108(49):2495-7. PubMed ID: 5340041
    [No Abstract]   [Full Text] [Related]  

  • 39. [Renal dynamics in acute uremia].
    Arroyo JL; Lampreave I; Palop L; Pérez Miranda M; Ortiz de Lándazuri E
    Prensa Med Argent; 1971 Dec; 58(43):2067-76. PubMed ID: 5158057
    [No Abstract]   [Full Text] [Related]  

  • 40. Diuretic and renal protective effects of 8-(noradamantan-3-yl)-1,3-dipropylxanthine (KW-3902), a novel adenosine A1-receptor antagonist, via pertussis toxin insensitive mechanism.
    Mizumoto H; Karasawa A; Kubo K
    J Pharmacol Exp Ther; 1993 Jul; 266(1):200-6. PubMed ID: 8331558
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.